MERTK and malignant colon neoplasm: Our data showed that benzyl‐α‐GalNAc treatment decreased the molecular weight of TYRO3 and MERTK (Fig. S5), suggesting that O‐glycans are also present in TYRO3 and MERTK in colon cancer cells.